Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-014203
Filing Date
2025-02-14
Accepted
2025-02-14 16:32:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9607
  Complete submission text file 0001104659-25-014203.txt   11342
Mailing Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840 203-404-1172
Nantahala Capital Management, LLC (Filed by) CIK: 0001472322 (see all company filings)

EIN.: 201151760 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Subject) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91207 | Film No.: 25629786
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)